Brief: Onxeo FY consolidated net loss widens to 19.4 million euros

Valerio Therapeutics SA

26/02/2016 16:45

Feb 26 (Reuters) - Onxeo SA  C4X.PA : 
    * FY cash position of EUR 33.6 million, confirming 
visibility until mid-2017 
    * FY operating loss of EUR 22.4 million versus loss of EUR 
5.5 million year ago 
    * FY consolidated net loss of EUR 19.4 million versus loss 
of EUR 7.7 million year ago 
    * FY revenue EUR  3.5 million versus EUR 22.1 million year 
ago 
 
Source text for Eikon:  ID:nBw4jpdfqa  
Further company coverage:  C4X.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 6983920;))